FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312065346> ?p ?o ?g. }

• W4312065346 endingPage "124" @default.
• W4312065346 startingPage "117" @default.
• W4312065346 abstract "<b><i>Introduction:</i></b> Severe COVID-19 illness can lead to thrombotic complications, organ failure, and death. Antithrombin (AT) regulates thromboinflammation and is a key component of chemical thromboprophylaxis. Our goal was to examine the link between AT activity and responsiveness to thromboprophylaxis, markers of hypercoagulability, and inflammation among severe COVID-19 patients. <b><i>Methods:</i></b> This was a single-center, prospective observational study enrolling SARS-CoV-2-positive patients admitted to the intensive care unit on prophylactic enoxaparin. Blood was collected daily for 7 days to assess AT activity and anti-factor Xa levels. Patient demographics, outcomes, and hospital laboratory results were collected. Continuous variables were compared using Mann-Whitney tests, and categorical variables were compared using χ² tests. Multivariable logistic regression was used to determine the association between AT activity and mortality. <b><i>Results:</i></b> In 36 patients, 3 thromboembolic events occurred, and 18 (50%) patients died. Patients who died had higher fibrinogen, D-dimer, and C-reactive protein (CRP) levels and lower AT activity. Reduced AT activity was independently associated with mortality and correlated with both markers of hypercoagulability (D-dimer) and inflammation (CRP). <b><i>Conclusion:</i></b> Low AT activity is associated with mortality and persistent hypercoagulable and proinflammatory states in severe COVID-19 patients. The anti-thromboinflammatory properties of AT make it an appealing therapeutic target for future studies." @default.
• W4312065346 created "2023-01-04" @default.
• W4312065346 creator A5005923687 @default.
• W4312065346 creator A5026987725 @default.
• W4312065346 creator A5055279687 @default.
• W4312065346 creator A5056060130 @default.
• W4312065346 creator A5070244523 @default.
• W4312065346 creator A5070948380 @default.
• W4312065346 creator A5073568638 @default.
• W4312065346 creator A5082212220 @default.
• W4312065346 creator A5090675988 @default.
• W4312065346 date "2022-12-20" @default.
• W4312065346 modified "2023-10-12" @default.
• W4312065346 title "Antithrombin Activity Is Associated with Persistent Thromboinflammation and Mortality in Patients with Severe COVID-19 Illness" @default.
• W4312065346 cites W2005888993 @default.
• W4312065346 cites W2175097202 @default.
• W4312065346 cites W2238441516 @default.
• W4312065346 cites W2523897893 @default.
• W4312065346 cites W2892226813 @default.
• W4312065346 cites W2968909610 @default.
• W4312065346 cites W3000425456 @default.
• W4312065346 cites W3012232836 @default.
• W4312065346 cites W3012860481 @default.
• W4312065346 cites W3016319555 @default.
• W4312065346 cites W3016641669 @default.
• W4312065346 cites W3017326650 @default.
• W4312065346 cites W3048838336 @default.
• W4312065346 cites W3112248954 @default.
• W4312065346 cites W3121280820 @default.
• W4312065346 cites W3123225191 @default.
• W4312065346 cites W3170764272 @default.
• W4312065346 cites W3203866192 @default.
• W4312065346 cites W4283324702 @default.
• W4312065346 doi "https://doi.org/10.1159/000528584" @default.
• W4312065346 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36538905" @default.
• W4312065346 hasPublicationYear "2022" @default.
• W4312065346 type Work @default.
• W4312065346 citedByCount "1" @default.
• W4312065346 countsByYear W43120653462023 @default.
• W4312065346 crossrefType "journal-article" @default.
• W4312065346 hasAuthorship W4312065346A5005923687 @default.
• W4312065346 hasAuthorship W4312065346A5026987725 @default.
• W4312065346 hasAuthorship W4312065346A5055279687 @default.
• W4312065346 hasAuthorship W4312065346A5056060130 @default.
• W4312065346 hasAuthorship W4312065346A5070244523 @default.
• W4312065346 hasAuthorship W4312065346A5070948380 @default.
• W4312065346 hasAuthorship W4312065346A5073568638 @default.
• W4312065346 hasAuthorship W4312065346A5082212220 @default.
• W4312065346 hasAuthorship W4312065346A5090675988 @default.
• W4312065346 hasBestOaLocation W43120653461 @default.
• W4312065346 hasConcept C126322002 @default.
• W4312065346 hasConcept C2776376669 @default.
• W4312065346 hasConcept C2777557582 @default.
• W4312065346 hasConcept C2779026020 @default.
• W4312065346 hasConcept C2779036427 @default.
• W4312065346 hasConcept C2781287897 @default.
• W4312065346 hasConcept C71924100 @default.
• W4312065346 hasConcept C90924648 @default.
• W4312065346 hasConceptScore W4312065346C126322002 @default.
• W4312065346 hasConceptScore W4312065346C2776376669 @default.
• W4312065346 hasConceptScore W4312065346C2777557582 @default.
• W4312065346 hasConceptScore W4312065346C2779026020 @default.
• W4312065346 hasConceptScore W4312065346C2779036427 @default.
• W4312065346 hasConceptScore W4312065346C2781287897 @default.
• W4312065346 hasConceptScore W4312065346C71924100 @default.
• W4312065346 hasConceptScore W4312065346C90924648 @default.
• W4312065346 hasIssue "2" @default.
• W4312065346 hasLocation W43120653461 @default.
• W4312065346 hasLocation W43120653462 @default.
• W4312065346 hasLocation W43120653463 @default.
• W4312065346 hasOpenAccess W4312065346 @default.
• W4312065346 hasPrimaryLocation W43120653461 @default.
• W4312065346 hasRelatedWork W1969503464 @default.
• W4312065346 hasRelatedWork W1984202930 @default.
• W4312065346 hasRelatedWork W2059415529 @default.
• W4312065346 hasRelatedWork W2066809508 @default.
• W4312065346 hasRelatedWork W2078913473 @default.
• W4312065346 hasRelatedWork W2088482881 @default.
• W4312065346 hasRelatedWork W2326474248 @default.
• W4312065346 hasRelatedWork W2359590982 @default.
• W4312065346 hasRelatedWork W2413134857 @default.
• W4312065346 hasRelatedWork W48031831 @default.
• W4312065346 hasVolume "146" @default.
• W4312065346 isParatext "false" @default.
• W4312065346 isRetracted "false" @default.
• W4312065346 workType "article" @default.